Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 22 May

Jessica Amir
May 22, 2020

Morning Bell 21 May

Jessica Amir
May 21, 2020

Morning Bell 20 May

Jessica Amir
May 20, 2020

Morning Bell 19 May

Jessica Amir
May 19, 2020

Morning Bell 18 May

Jessica Amir
May 18, 2020

Weekly Wrap 15 May

Jessica Amir
May 15, 2020

Morning Bell 15 May

Jessica Amir
May 15, 2020

Morning Bell 14 May

Jessica Amir
May 14, 2020

Morning Bell 13 May

Jessica Amir
May 13, 2020

Morning Bell 12 May

Jessica Amir
May 12, 2020

Morning Bell 11 May

Jessica Amir
May 11, 2020

Weekly Wrap 8 May

Jessica Amir
May 8, 2020